Host Conditioning Is a Primary Determinant in Modulating the Effect of IL-7 on Murine Graft-versus-Host Disease1

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Immunology

• Publication date

  2004-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.172.5.3328PMID 14978141
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation.

  2002cited by this paper
• Reconstitution of thymic function after stem cell transplantation in humans

  2002cited by this paper
• Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation1

  2002cited by this paper
• Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease.

  2002cited by this paper
• Interleukin 7 worsens graft-versus-host disease.

  2002cited by this paper
• Role of the Passive Apoptotic Pathway in Graft-Versus-Host Disease1

  2002cited by this paper
• Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation.

  2001cited by this paper
• Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.

  2001cited by this paper
• IL-7 is critical for homeostatic proliferation and survival of naïve T cells

  2001cited by this paper
• Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation.

  2001cited by this paper
• A potential role for interleukin-7 in T-cell homeostasis.

  2001cited by this paper
• IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation.

  2001cited by this paper
• IL-7 Enhances the Survival and Maintains the Size of Naive T Cells1

  2001cited by this paper
• Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis

  2001cited by this paper
• Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning.

  2000cited by this paper
• Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation.

  2000cited by this paper
• Graft-Versus-host Disease

  1999cited by this paper
• Dose and timing of interleukin (IL)-12 and timing and type of total-body irradiation: effects on graft-vs.-host disease inhibition and toxicity of exogenous IL-12 in murine bone marrow transplant recipients.

  1999cited by this paper
• Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profiles.

  1999cited by this paper
• Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count

  1999cited by this paper
• Massive activation-induced cell death of alloreactive T cells with apoptosis of bystander postthymic T cells prevents immune reconstitution in mice with graft-versus-host disease.

  1999cited by this paper
• Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions.

  1999cited by this paper
• Massive Activation-Induced Cell Death of Alloreactive T Cells With Apoptosis of Bystander Postthymic T Cells Prevents Immune Reconstitution in Mice With Graft-Versus-Host Disease

  1999cited by this paper
• Comparison of Immune Reconstitution After Unrelated and Related T-Cell – Depleted Bone Marrow Transplantation : Effect of Patient Age and Donor Leukocyte Infusions

  1998cited by this paper
• The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation.

  1998cited by this paper
• Human dendritic cells express functional interleukin-7.

  1998cited by this paper
• Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis.

  1997cited by this paper
• Interleukin-7 Upregulates the Interleukin-2–Gene Expression in Activated Human T Lymphocytes at the Transcriptional Level by Enhancing the DNA Binding Activities of Both Nuclear Factor of Activated T Cells and Activator Protein-1

  1997cited by this paper
• Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

  1997cited by this paper
• Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.

  1997cited by this paper
• Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice.

  1996cited by this paper
• Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7.

  1996cited by this paper
• IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms.

  1996cited by this paper
• Human follicular dendritic cells and vascular cells produce interleukin‐7: a potential role for interleukin‐7 in the germinal center reaction

  1996cited by this paper
• Synergistic effects of IL-7 and IL-12 on human T cell activation.

  1995cited by this paper
• IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation.

  1995cited by this paper
• Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

  1995cited by this paper
• IL-2-induced GVHD protection is not inhibited by cyclosporine and is maximal when IL-2 is given over a 25 h period beginning on the day following bone marrow transplantation.

  1995cited by this paper
• Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice.

  1994cited by this paper
• Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo

  1994cited by this paper
• Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions

  1993cited by this paper
• Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts.

  1993cited by this paper
• Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose.

  1993cited by this paper
• Interleukin (IL1 to IL7) gene expression in fetal liver and bone marrow stromal clones: cytokine-mediated positive and negative regulation.

  1992cited by this paper
• Interleukin‐7 expression during mouse thymus development

  1992cited by this paper
• Cytokine dysregulation and acute graft-versus-host disease.

  1992cited by this paper
• Constitutive Expression of Interleukin‐7 mRNA and Production of IL‐7 by a Cloned Murine Thymic Stromal Cell Line

  1990cited by this paper
• Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance.

  1990cited by this paper
• Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts.

  1989cited by this paper

• Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective.

  2025cites this paper
• Murine models of graft versus host disease (GVHD): Focus on ocular GVHD.

  2023cites this paper
• Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease.

  2020cites this paper
• IL-7 Is the Limiting Homeostatic Factor that Constrains Homeostatic Proliferation of CD8+ T Cells after Allogeneic Stem Cell Transplantation and Graft-versus-Host Disease.

  2019cites this paper
• Strategies to Improve Posttransplant Immunity

  2019cites this paper
• An update on: meta-analysis of medical and non-medicaltreatments of the prodromal phase of psychotic illness in at risk mental states.

  2016cites this paper
• The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview

  2016cites this paper
• Identification of genes regulated in target organs of acute graft versus host disease in different organs in different species

  2016cites this paper
• Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4(+) T Cells after Allogeneic Stem Cell Transplantation.

  2015cites this paper
• Strategies to improve post-transplant immunity

  2013cites this paper
• Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.

  2012cites this paper
• Recombinant human interleukin-7 ( CYT 107 ) promotes T-cell recovery after allogeneic stem cell transplantation

  2012cites this paper
• Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)?

  2012cites this paper
• Nonalloreactive T Cells Prevent Donor Lymphocyte Infusion–Induced Graft-versus-Host Disease by Controlling Microbial Stimuli

  2012cites this paper
• Cellular Therapy for Hematology Malignancies: Allogeneic Hematopoietic Stem Transplantation, Graft-Versus-Host Disease, and Graft Versus Leukemia Effects

  2012cites this paper
• after allogeneic stem cell transplantation Recombinant human interleukin-7 (CYT107) promotes T-cell recovery

  2012cites this paper
• Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD

  2011cites this paper
• Mouse models of graft-versus-host disease: advances and limitations

  2011cites this paper
• The Experimental Model of the Autoimmune Glomerulonephritis Induced by the Chronic Graft versus Host Reaction

  2011cites this paper
• An Update on Glomerulopathies - Etiology and Pathogenesis

  2011cites this paper
• Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse

  2010cites this paper
• Regulatory T cells and immune tolerance after allogeneic hematopoietic stem cell transplantation

  2010cites this paper
• IL-7 Enhances Survival of Human CD56bright NK Cells

  2010cites this paper
• Les cytokines homéostatiques, IL-7 et IL-15, au cours de l'allogreffe de CSH : leurs évolutions selon le conditionnement et leurs valeurs prédictives de la GVH aiguë et de la rechute

  2010cites this paper
• Thymic involution and immune reconstitution.

  2009cites this paper
• Mouse models of graft-versus-host disease

  2009cites this paper
• Clinical Strategies to enhance post-transplant immune reconstitution Notch-mediated Regulation of Hematopoiesis

  2009cites this paper
• The C ontribution of Homeostatically Expanded Donor CD8 T Cells to Host Reconstitution Following Syngeneic Hematopoietic Cell Transplantation

  2008cites this paper
• Pathophysiology of Acute Graft-vs-Host Disease: Recent Advances

  2008cites this paper
• Importance of interleukin-7 in the development of experimental graft-versus-host disease.

  2008cites this paper
• Clinical strategies to enhance posttransplant immune reconstitution.

  2008cites this paper
• Association of serum interleukin-7 levels with the development of acute graft-versus-host disease.

  2008cites this paper
• Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients.

  2008cites this paper
• Pathophysiology of acute graft-versus-host disease: recent advances.

  2007cites this paper
• IL-7-mediated protection against minor-antigen-mismatched allograft rejection is associated with enhanced recovery of regulatory T cells.

  2007cites this paper
• Clinical strategies to enhance T cell reconstitution.

  2007cites this paper
• Prevention of graft-versus-host disease by anti IL-7Ralpha antibody.

  2007cites this paper
• IL-7: griffinesque role in GVHD

  2007cites this paper
• T cell immune reconstitution following lymphodepletion.

  2007cites this paper
• Prevention of graft-versus-host disease by anti–IL-7Rα antibody

  2007cites this paper
• Prevention of graft-versus-host disease by anti–IL-7R (cid:1) antibody

  2007cites this paper
• IL-7 Is a Critical Factor in Modulating Lesion Development in Skn-Directed Autoimmunity1

  2006cites this paper
• Neutralizing IL‐7 Promotes Long‐Term Allograft Survival Induced by CD40/CD40L Costimulatory Blockade

  2006cites this paper
• Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment.

  2006cites this paper
• Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD)

  2005cites this paper
• IL-7 and IL-15: therapeutic cytokines for immunodeficiency.

  2005cites this paper
• The Pathophysiology of Acute Graft-versus-Host Disease

  2003cites this paper
• Enhanced Posttransplant T Cell Reconstitution With Interleukin-7 , Keratinocyte Growth Factor , and Lymphoid Precursors

  year unknowncites this paper
• Mouse Models of Graft-versus-host Disease: Advances and Limitations Recommended Citation Introduction Gvhd Immunopathology in Humans and Mice Mouse Models of Graft-versus-host Disease: Advances and Limitations Box 1. Glossary of Immunological Terms Mouse Models of Gvhd

  year unknowncites this paper